Cognito Therapeutics announced that at the 2025 C
Author: Michael
The company expands its Phase 1 trial after earl
Researchers reveal a new way to harness the micr
New collaboration aims to bring clarity, credibi
Professor John Beard reflects on the societal sh
Scientists refine microglia replacement as a pot
Morphocell’s expanded Series A funding strengt
With programs targeting Alzheimer’s and Parkin
Longeveron announced that the Canadian Intellectu
Insilico Medicine has published the discovery of